nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ADRB2—polycystic ovary syndrome	0.807	1	CbGaD
Penbutolol—Timolol—ADRB3—polycystic ovary syndrome	0.00233	0.173	CrCbGaD
Penbutolol—Nadolol—ADRB3—polycystic ovary syndrome	0.00185	0.138	CrCbGaD
Penbutolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.00177	0.131	CrCbGaD
Penbutolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.00135	0.101	CrCbGaD
Penbutolol—Levobunolol—ADRB2—polycystic ovary syndrome	0.000928	0.0691	CrCbGaD
Penbutolol—Timolol—ADRB2—polycystic ovary syndrome	0.000886	0.0659	CrCbGaD
Penbutolol—Carteolol—ADRB2—polycystic ovary syndrome	0.000789	0.0587	CrCbGaD
Penbutolol—Nadolol—ADRB2—polycystic ovary syndrome	0.000704	0.0524	CrCbGaD
Penbutolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.000671	0.0499	CrCbGaD
Penbutolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000635	0.0472	CrCbGaD
Penbutolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000563	0.0419	CrCbGaD
Penbutolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000514	0.0383	CrCbGaD
Penbutolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000241	0.018	CrCbGaD
Penbutolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000207	0.0154	CrCbGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.33e-05	0.000463	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.33e-05	0.000463	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INHBB—polycystic ovary syndrome	8.31e-05	0.000462	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	8.29e-05	0.000461	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.2e-05	0.000456	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.18e-05	0.000455	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.18e-05	0.000455	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.16e-05	0.000454	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.15e-05	0.000453	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	8.11e-05	0.000451	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.1e-05	0.00045	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.02e-05	0.000446	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.01e-05	0.000445	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.98e-05	0.000444	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	7.97e-05	0.000443	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	7.93e-05	0.000441	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.92e-05	0.00044	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	7.83e-05	0.000435	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.8e-05	0.000434	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	7.77e-05	0.000432	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.76e-05	0.000431	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.75e-05	0.000431	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.69e-05	0.000427	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.69e-05	0.000427	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	7.6e-05	0.000422	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	7.59e-05	0.000422	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.57e-05	0.000421	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.52e-05	0.000418	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.52e-05	0.000418	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	7.43e-05	0.000413	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.41e-05	0.000412	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.35e-05	0.000409	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.35e-05	0.000409	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.25e-05	0.000403	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.24e-05	0.000402	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.19e-05	0.0004	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.09e-05	0.000394	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.08e-05	0.000393	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FSHR—polycystic ovary syndrome	7.07e-05	0.000393	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.04e-05	0.000391	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.98e-05	0.000388	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.92e-05	0.000385	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—POMC—polycystic ovary syndrome	6.92e-05	0.000385	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.88e-05	0.000382	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.87e-05	0.000382	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.83e-05	0.00038	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.79e-05	0.000378	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.68e-05	0.000371	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.64e-05	0.000369	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.64e-05	0.000369	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.62e-05	0.000368	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.5e-05	0.000361	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.47e-05	0.00036	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.46e-05	0.000359	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	6.33e-05	0.000352	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FST—polycystic ovary syndrome	6.3e-05	0.00035	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	6.26e-05	0.000348	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	6.22e-05	0.000346	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.18e-05	0.000343	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	6.15e-05	0.000342	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.04e-05	0.000336	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.03e-05	0.000335	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.01e-05	0.000334	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.91e-05	0.000329	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.89e-05	0.000328	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.82e-05	0.000323	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.81e-05	0.000323	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.76e-05	0.00032	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	5.76e-05	0.00032	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.69e-05	0.000316	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.63e-05	0.000313	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.51e-05	0.000306	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.51e-05	0.000306	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.5e-05	0.000305	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.47e-05	0.000304	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	5.4e-05	0.0003	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.39e-05	0.0003	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	5.38e-05	0.000299	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	5.36e-05	0.000298	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.35e-05	0.000298	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.29e-05	0.000294	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.27e-05	0.000293	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	5.27e-05	0.000293	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.25e-05	0.000292	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.23e-05	0.000291	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.18e-05	0.000288	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.15e-05	0.000286	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.06e-05	0.000281	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.03e-05	0.00028	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.02e-05	0.000279	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	5e-05	0.000278	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.99e-05	0.000277	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.95e-05	0.000275	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	4.93e-05	0.000274	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.92e-05	0.000274	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	4.91e-05	0.000273	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	4.9e-05	0.000272	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.85e-05	0.000269	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	4.8e-05	0.000267	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	4.79e-05	0.000266	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.79e-05	0.000266	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.77e-05	0.000265	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.74e-05	0.000263	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	4.71e-05	0.000262	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	4.68e-05	0.00026	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.68e-05	0.00026	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.63e-05	0.000258	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.62e-05	0.000257	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	4.59e-05	0.000255	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.58e-05	0.000254	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.53e-05	0.000252	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.53e-05	0.000252	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.52e-05	0.000251	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.49e-05	0.000249	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.48e-05	0.000249	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.43e-05	0.000246	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.42e-05	0.000246	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.41e-05	0.000245	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	4.39e-05	0.000244	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.38e-05	0.000243	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	4.37e-05	0.000243	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.33e-05	0.000241	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.3e-05	0.000239	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.28e-05	0.000238	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.26e-05	0.000237	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.21e-05	0.000234	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.2e-05	0.000233	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.19e-05	0.000233	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.17e-05	0.000232	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	4.11e-05	0.000229	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.11e-05	0.000228	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	4.08e-05	0.000227	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	4.06e-05	0.000226	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	4.06e-05	0.000226	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.02e-05	0.000223	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.98e-05	0.000221	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.93e-05	0.000218	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.91e-05	0.000217	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.89e-05	0.000217	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	3.87e-05	0.000215	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.84e-05	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	3.81e-05	0.000212	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.78e-05	0.00021	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.76e-05	0.000209	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	3.76e-05	0.000209	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	3.75e-05	0.000209	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.67e-05	0.000204	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	3.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	3.57e-05	0.000199	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.57e-05	0.000198	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	3.55e-05	0.000197	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	3.54e-05	0.000197	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.51e-05	0.000195	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.49e-05	0.000194	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	3.48e-05	0.000193	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.44e-05	0.000191	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.41e-05	0.00019	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.41e-05	0.00019	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.4e-05	0.000189	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.36e-05	0.000187	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.36e-05	0.000187	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	3.33e-05	0.000185	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.23e-05	0.00018	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.23e-05	0.00018	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.16e-05	0.000176	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.16e-05	0.000176	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	3.12e-05	0.000173	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.11e-05	0.000173	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	3.09e-05	0.000172	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	3.09e-05	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.08e-05	0.000171	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.05e-05	0.000169	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.02e-05	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.01e-05	0.000167	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.99e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.98e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.97e-05	0.000165	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.95e-05	0.000164	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.94e-05	0.000164	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.93e-05	0.000163	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	2.91e-05	0.000162	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.88e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.86e-05	0.000159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.85e-05	0.000158	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.83e-05	0.000157	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.82e-05	0.000157	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.78e-05	0.000155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.77e-05	0.000154	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.76e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.72e-05	0.000151	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.72e-05	0.000151	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.7e-05	0.00015	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	2.7e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.68e-05	0.000149	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.66e-05	0.000148	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.6e-05	0.000145	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.56e-05	0.000142	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	2.49e-05	0.000139	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.48e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	2.44e-05	0.000136	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.43e-05	0.000135	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	2.37e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.36e-05	0.000131	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.32e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.31e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.27e-05	0.000126	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.26e-05	0.000126	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.22e-05	0.000123	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	2.18e-05	0.000121	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	2.1e-05	0.000117	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	2.09e-05	0.000116	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.02e-05	0.000112	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.02e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.99e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.94e-05	0.000108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.94e-05	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.92e-05	0.000107	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.9e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.9e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.86e-05	0.000103	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.73e-05	9.64e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.7e-05	9.43e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.67e-05	9.29e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.66e-05	9.23e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.66e-05	9.22e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.63e-05	9.08e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.62e-05	9.03e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.61e-05	8.93e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.61e-05	8.93e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.6e-05	8.88e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	1.59e-05	8.83e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.57e-05	8.74e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.57e-05	8.73e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.54e-05	8.58e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.54e-05	8.54e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.54e-05	8.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.53e-05	8.48e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.49e-05	8.3e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.46e-05	8.11e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.32e-05	7.33e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.23e-05	6.83e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.2e-05	6.68e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.18e-05	6.53e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.05e-05	5.83e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.03e-05	5.71e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1e-05	5.58e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	9.11e-06	5.07e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	7.26e-06	4.04e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7.1e-06	3.95e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	6.94e-06	3.86e-05	CbGpPWpGaD
